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LETTERS TO THE EDITOR
Atrial Fibrillation Ablation:
Role of Patient Enrollment
and Follow-Up in Clinical Results
In the August 7, 2002, issue of the Journal, Marrouche et al. (1)
reported their experience about circular mapping and ablation of
the pulmonary vein (PV) for treatment of atrial fibrillation (AF).
In group 2 (190) patients they reported, during a follow-up of 10
months, a success rate of 94% in paroxysmal AF, 90% in persistent
AF, and 80% in permanent AF. They concluded that isolation of
focal triggers initiating in PV appeared an effective cure for AF
independently from the duration of AF and left atrial site.
Pappone et al. (2), with Carto (three-dimension electroana-
tomical mapping)-assisted anatomical encircling of PV, reported
85% and 68% success rates for paroxysmal and permanent AF,
respectively. Haissaguerre et al. (3), with electrophysiologic PV
insulation (similar to Marrouche’s) reported clinical success rates of
93%, 73%, and 55% in patients with 1, 2, and 3 or more arrhythmo-
genic PV foci in paroxysmal AF (mean of 74%) and 60% in chronic
AF where left atrial size appears to be a limiting factor (4).
The reason for better results by Marrouche et al. (1) could be
found in patient enrollment and/or follow-up. Concerning enroll-
ment, was it selective or not? If the investigators enrolled only
patients in whom PV focal trigger initiated AF (documented?),
especially in paroxysmal AF, the results might not be comparable
with other studies. Moreover, in patients with coexisting atrial
flutter and AF, was PV ablation combined with right isthmus
ablation? Nabar et al. (5) demonstrated that patients who have
recurrences of both atrial flutter and AF could be cured by safer
inferior vena cava to tricuspid annulus (IVC-TA) isthmus ablation
only: they showed up to 73% success rate. Our experience (6)
confirmed that if atrial flutter is detected during infusion of 1C
antiarrhythmic drug for AF (1C atrial flutter), right isthmus
ablation is highly effective in curing AF.
The follow-up was scheduled at 1, 3, 6, and 12 months’
postablation; Holter recording was made before discharge and at 3
and 6 months. Scheduled electrocardiogram (ECG) or Holter
ECG monitoring could not be effective in detecting short-lasting
paroxysmal AF episodes, because Savelieva et al. (7) documented a
high incidence of asymptomatic AF episodes in patients with AF
treated by cardioversion. Van Noord et al. (8) in the VERDICT study
indicate that daily transtelephone ECG recording is an effective
method to detect arrhythmia recurrence in follow-up of AF patients.
We are convinced that daily transtelephone ECG recording is
effective in monitoring AF patients cured by PV isolation (elec-
trophysiologic or anatomical approach) during follow-up; because
it is expensive treatment, it could be used for three months only
(for example, from the 3rd to 15th week) and then weekly.
Finally, Marrouche et al. do not mention the incidence of left or
right atrial flutter as reported by others (3). Again, the answer may
be patient selection, because the more damaged the atrium the
more sensitive to slow conduction and reentry around anatomical
obstacle.
Thus, to avoid atrial flutter we routinely perform PV encircling
ablation with linear right (IVC-TA) and left (from mitral annulus
to low pulmonary vein) isthmus ablation with electrophysiological
validation (no-linked double potential on ablation line during
moving pacing site).
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REPLY
We thank Dr. Turco and colleagues for the opportunity of
clarifying important issues relative to our experience with ablation
of atrial fibrillation.
The answers to most of their queries are indeed included in the
August 7, 2002, series reported in the Journal (1). Turco and
colleagues mentioned the Pappone et al. experience (2) with
CARTO-assisted encircling of the pulmonary veins (PVs). In our
laboratory we have used CARTO to isolate PVs, with poor results
and high incidence of PV stenosis (3). We showed that with
CARTO, we were able to isolate only 31% of the targeted PVs.
The overall cure rate was about 21%, with nearly 17% occurrence
of severe PV stenosis. In addition, in the CARTO cohort we
observed nearly a 20% occurrence of left atrial flutter at follow-up.
In most of the patients, left atrial flutter reflected the inability to
isolate the veins and cure atrial fibrillation (AF).
Haissaguerre et al. (4) have pioneered the circular mapping
approach. However, in their initial report the investigators most
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